(Q50989183)

26 March 2018

title

Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. (English)

1 reference

26 March 2018

1 reference

2

1 reference

26 March 2018

author name string

J P Kelly

1

1 reference

26 March 2018

J M Jurgelon

3

1 reference

26 March 2018

J Sheehan

4

1 reference

26 March 2018

R S Koff

5

1 reference

26 March 2018

S Shapiro

6

1 reference

26 March 2018

language of work or name

English

0 references

publication date

1 November 1996

1 reference

26 March 2018

published in

The Lancet

1 reference

26 March 2018

volume

348

1 reference

26 March 2018

issue

9039

1 reference

26 March 2018

page(s)

1413-1416

1 reference

26 March 2018

Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901254-8

7 January 2021

Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901254-8

7 January 2021

Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901254-8

7 January 2021

Nonsteroidal anti-inflammatory drugs and gastrointestinal bleeding. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901254-8

7 January 2021

The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901254-8

7 January 2021

Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901254-8

7 January 2021

Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901254-8

7 January 2021

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901254-8

7 January 2021

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901254-8

7 January 2021

Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901254-8

7 January 2021

Aspirin and the stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901254-8

7 January 2021

Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901254-8

7 January 2021

Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901254-8

7 January 2021

Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901254-8

7 January 2021

Incidence of Gastric Lesions in Patients with Rheumatic Disease on Chronic Aspirin Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901254-8

7 January 2021

Estimability and estimation in case-referent studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901254-8

7 January 2021

A reevaluation of aspirin therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901254-8

7 January 2021

Prophylactic aspirin and risk of peptic ulcer bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901254-8

7 January 2021

10.1016/S0140-6736(96)01254-8

Identifiers

DOI

1 reference

26 March 2018

PubMed ID

8937281

1 reference

26 March 2018